These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9463852)

  • 41. Sample size re-estimation for survival data in clinical trials with an adaptive design.
    Togo K; Iwasaki M
    Pharm Stat; 2011; 10(4):325-31. PubMed ID: 22328325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiplicity and flexibility in clinical trials.
    Brannath W; Koenig F; Bauer P
    Pharm Stat; 2007; 6(3):205-16. PubMed ID: 17674349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pilot and Repeat Trials as Development Tools Associated with Demonstration of Bioequivalence.
    Fuglsang A
    AAPS J; 2015 May; 17(3):678-83. PubMed ID: 25732246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes.
    Shih WJ; Zhao PL
    Stat Med; 1997 Sep; 16(17):1913-23. PubMed ID: 9304763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A variational approach to optimal two-stage designs.
    Pilz M; Kunzmann K; Herrmann C; Rauch G; Kieser M
    Stat Med; 2019 Sep; 38(21):4159-4171. PubMed ID: 31264243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation by simulation of clinical trial designs for evaluation of treatment during a viral haemorrhagic fever outbreak.
    Manchon P; Belhadi D; Mentré F; Laouénan C
    BMC Med Res Methodol; 2021 May; 21(1):98. PubMed ID: 33952195
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sample size re-estimation: recent developments and practical considerations.
    Gould AL
    Stat Med; 2001 Sep 15-30; 20(17-18):2625-43. PubMed ID: 11523073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A SAS macro for sample size adjustment and randomization test for internal pilot study.
    Wang S; Xia J; Yu L; Li C; Xu L
    Comput Methods Programs Biomed; 2008 Apr; 90(1):66-88. PubMed ID: 18192069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blinded and unblinded internal pilot study designs for clinical trials with count data.
    Schneider S; Schmidli H; Friede T
    Biom J; 2013 Jul; 55(4):617-33. PubMed ID: 23703749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adaptive designs: The Swiss Army knife among clinical trial designs?
    Bretz F; Gallo P; Maurer W
    Clin Trials; 2017 Oct; 14(5):417-424. PubMed ID: 28982262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimized adaptive enrichment designs for three-arm trials: learning which subpopulations benefit from different treatments.
    Steingrimsson JA; Betz J; Qian T; Rosenblum M
    Biostatistics; 2021 Apr; 22(2):283-297. PubMed ID: 31420983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim.
    Posch M; Maurer W; Bretz F
    Pharm Stat; 2011; 10(2):96-104. PubMed ID: 22328314
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blinded sample size reestimation with count data: methods and applications in multiple sclerosis.
    Friede T; Schmidli H
    Stat Med; 2010 May; 29(10):1145-56. PubMed ID: 20146203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adaptive sample size modification in clinical trials: start small then ask for more?
    Jennison C; Turnbull BW
    Stat Med; 2015 Dec; 34(29):3793-810. PubMed ID: 26172385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A group sequential, response-adaptive design for randomized clinical trials.
    Karrison TG; Huo D; Chappell R
    Control Clin Trials; 2003 Oct; 24(5):506-22. PubMed ID: 14500050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On Two-stage Seamless Adaptive Design in Clinical Trials.
    Chow SC; Tu YH
    J Formos Med Assoc; 2008 Dec; 107(12 Suppl):52-60. PubMed ID: 19129046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A multi-stage drop-the-losers design for multi-arm clinical trials.
    Wason J; Stallard N; Bowden J; Jennison C
    Stat Methods Med Res; 2017 Feb; 26(1):508-524. PubMed ID: 25228636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimal flexible sample size design with robust power.
    Zhang L; Cui L; Yang B
    Stat Med; 2016 Aug; 35(19):3385-96. PubMed ID: 26999385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sample size re-estimation in crossover trials: application to the AIM HY-INFORM study.
    Wych J; Grayling MJ; Mander AP
    Trials; 2019 Dec; 20(1):665. PubMed ID: 31791376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blinded sample size re-estimation in crossover bioequivalence trials.
    Golkowski D; Friede T; Kieser M
    Pharm Stat; 2014; 13(3):157-62. PubMed ID: 24715672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.